Beneficient (BENF) AI Stock Analysis

• Market Cap: $58.99M
• Dividend Yield: N/A
• Average Volume (3M): 23.74M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.18
• Revenue Growth: -33.98%
• EPS Growth: 94.83%
• Country: US
• Employees: 80
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): 0.04
• Shares Outstanding: 14,183,822
• 10 Day Avg. Volume: 1,028,732
• 30 Day Avg. Volume: 23,735,752
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.01
• Price to Sales (P/S): -0.23
• P/FCF Ratio: -0.05
• Enterprise Value/Market Cap: -0.05
• Enterprise Value/Revenue: 0.20
• Enterprise Value/Gross Profit: 0.14
• Enterprise Value/Ebitda: 0.04
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: $3.50 ▼(-31.77% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held down primarily by weak financial performance (sharp revenue decline, ongoing losses, and persistent cash burn) and bearish technicals (below key moving averages with negative MACD). Earnings call commentary adds some stabilization positives (cost cuts, compliance regained, debt actions), but significant operating deterioration and legal/balance-sheet uncertainty remain key risks; valuation offers limited support due to negative earnings and no indicated dividend.

Positive Factors

Diversified collateral

A broad collateral base across ~150 funds and ~430 underlying investments supports loan recoveries and reduces single-manager concentration risk. This structural diversification helps stabilize credit performance for the liquidity platform and underpins the firm’s ability to scale lending capacity over multiple market cycles.

Legal overhang largely resolved

Court-approved GWG settlement removes a material litigation overhang and permits management to refocus on core operations. By resolving those claims within insurance limits, the company reduces near-term contingent liability risk and clears a structural barrier to rebuilding client relationships and executing long-term strategy.

Expense cuts & tech focus

Sustained expense reductions plus a plan to deploy an AI-enhanced platform create durable margin improvement potential. Lower fixed costs and productivity gains from technology can lengthen the runway, improve per-transaction economics, and make the liquidity and GP-primary business more scalable over the medium term.

Negative Factors

Sharp revenue decline

A near-50% TTM revenue decline and persistent operating losses indicate structural deterioration in core fee and financing businesses. Eroding top-line reduces operating leverage, weakens recurring fee streams, and lengthens the timeline to achieve sustainable profitability absent material business model recovery or new revenue channels.

Weak cash generation

Consistent negative operating and free cash flow creates ongoing funding pressure, forcing reliance on asset sales, capital raises or debt actions. Poor cash generation constrains reinvestment in growth initiatives, limits ability to execute on the pipeline, and raises solvency risk if losses persist over multiple quarters.

Balance-sheet & legal uncertainty

Very low cash versus substantial reported debt and active disputes tied to the former CEO create contingent liability and capital-structure risk. These unresolved claims and potential indemnities can impair financing options, divert management resources, and delay durable recovery even if operating fixes proceed.

Beneficient Business Overview & Revenue Model

Company Description

Beneficient (BENF) is a financial services company specializing in the management and liquidity of alternative investments. The company primarily operates within the private equity and alternative asset sectors, providing solutions that enhance the accessibility and usability of illiquid assets for institutional investors and high-net-worth individuals. Its core offerings include liquidity solutions, asset management services, and investment advisory services designed to facilitate transactions and optimize portfolio performance.

How the Company Makes Money

Beneficient generates revenue through several key streams, including fees from asset management, transaction facilitation, and advisory services. The company charges management fees for overseeing alternative investment portfolios and performance fees based on the returns generated for clients. Additionally, Beneficient earns revenue by providing liquidity solutions, which may involve facilitating the sale or financing of illiquid assets. Strategic partnerships with financial institutions and investment firms further enhance their service offerings and revenue potential, allowing them to tap into a broader client base and leverage complementary services.

Beneficient Financial Statement Overview

Summary

Weak operating picture: TTM revenue down ~49%, deeply negative profitability (negative EBIT/EBITDA/net income), and persistently negative operating and free cash flow. The main support is an improved TTM balance sheet (no debt and positive equity), but large historical equity swings and continued cash burn keep financial risk elevated.

Income Statement

TTM (Trailing-Twelve-Months) results show a sharp revenue decline (down ~49%) and deeply negative profitability (negative gross profit, EBIT, EBITDA, and net income). While some reported margin figures appear mechanically high due to negative revenue, the underlying picture is clear: the business is not generating positive operating earnings, and the earnings profile has been volatile across periods (including a one-off profit in the 2025 annual report against losses in other years).

Balance Sheet

Balance sheet quality is mixed. On the positive side, TTM (Trailing-Twelve-Months) shows no debt and positive equity, which materially reduces financial risk versus prior annual periods that carried meaningful debt and even negative equity. However, the large swing from negative equity (2023–2025 annual) to positive equity in TTM suggests capital structure instability and potential reliance on revaluations or corporate actions, which investors should treat with caution.

Cash Flow

Cash generation remains weak: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both meaningfully negative, and this pattern is consistent across the annual periods provided. Even where free cash flow tracks net income mathematically in some periods, the company is still burning cash, which raises funding risk if losses persist.

Breakdown	TTM	Jun 2025	Jun 2024	Mar 2023	Dec 2020	Dec 2019
Income Statement
Total Revenue	-14.86M	-7.95M	-98.91M	-104.99M	101.98M	60.29M
Gross Profit	-22.07M	-24.80M	-164.04M	-150.52M	81.20M	60.29M
EBITDA	-76.83M	-35.40M	-2.64B	-234.09M	-13.81M	-135.05M
Net Income	-49.57M	51.16M	-2.10B	-130.98M	-58.04M	-334.04M
Balance Sheet
Total Assets	337.86M	354.88M	368.50M	368.50M	3.14B	2.82B
Cash, Cash Equivalents and Short-Term Investments	7.87M	1.35M	7.91M	7.91M	70.59M	12.49M
Total Debt	0.00	117.90M	130.25M	130.25M	171.59M	256.34M
Total Liabilities	375.90M	299.27M	309.57M	309.57M	241.43M	282.84M
Stockholders Equity	90.53M	-167.00M	-234.35M	-234.35M	1.44B	621.50M
Cash Flow
Free Cash Flow	-43.58M	-38.80M	-59.98M	-97.19M	-57.23M	-54.17M
Operating Cash Flow	-43.18M	-37.70M	-58.22M	-95.12M	-54.01M	-51.19M
Investing Cash Flow	69.97M	28.11M	44.06M	63.02M	-5.98M	70.44M
Financing Cash Flow	-23.12M	2.97M	12.59M	-34.46M	43.86M	-5.24M

Beneficient Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 5.13
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BENF, the sentiment is Negative. The current price of 5.13 is above the 20-day moving average (MA) of 4.29, below the 50-day MA of 5.29, and above the 200-day MA of 3.97, indicating a bearish trend. The MACD of -0.37 indicates Positive momentum. The RSI at 40.33 is Neutral, neither overbought nor oversold. The STOCH value of 23.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BENF.

Beneficient Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
MLCI	59 Neutral	$6.91M	-2.69	-25.88%	1.07%	66.65%	-1497.99%
BCG	57 Neutral	$37.85M	59.17	5.87%	―	-37.08%	―
CWD	46 Neutral	$8.42M	-0.06	-1438.14%	―	-62.09%	-99.89%
BENF	42 Neutral	$58.99M	-0.04	―	―	-33.98%	94.83%
ATON	42 Neutral	$5.99M	>-0.01	―	―	―	―
BTTC	34 Underperform	$14.63M	-0.59	-109.09%	―	―	60.78%

Beneficient Corporate Events

Beneficient Secures Final Court Approval of GWG Settlement

On January 21, 2026, Beneficient announced that the U.S. District Court for the Northern District of Texas had approved a previously disclosed settlement agreement resolving all GWG Holdings-related lawsuits in that court against the company, its subsidiaries and current and former directors and officers; this follows a March 10, 2025 binding settlement agreement and a June 2025 approval by the U.S. Bankruptcy Court for the Southern District of Texas. The settlement, which is to be paid within applicable insurance policy limits and involves no admission of fault or liability by Beneficient or any defendant, fully and finally resolves the GWG litigation against the Beneficient parties and enables the company, according to interim CEO James Silk, to refocus on executing its business strategy, although certain GWG-related claims remain outstanding against entities tied to the former CEO, for which Beneficient may have indemnification obligations.

The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.

Beneficient Completes Early Loan Repayment, Strengthening Balance Sheet

On January 20, 2026, Beneficient announced it had repaid approximately $27.5 million in loans tied to a credit agreement originally entered into on October 19, 2023, with HH-BDH LLC (whose sole member is Hicks Holdings Operating, LLC) and a Texas state bank, fully satisfying all outstanding principal owed to the bank roughly ten months ahead of the loans’ original October 19, 2026 maturity date. While about $1.66 million in interest and fees remains payable to Hicks Holdings and has been deferred, the company emphasized that the early payoff eliminates its obligations to the bank under the credit agreement and will fully discharge its remaining commitments to Hicks Holdings once these outstanding amounts are settled, a move management framed as a significant milestone in strengthening the balance sheet, reducing leverage, and enhancing financial flexibility to pursue its strategic priorities and long-term value creation for shareholders.

The most recent analyst rating on (BENF) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.

Beneficient expands GP primary capital with Cork & Vines

On January 5, 2026, Beneficient funded the closing of a primary capital transaction involving a limited partner interest in an investment fund with a net asset value of about $3 million, issuing 302,273 shares of its newly designated Series B-9 Resettable Convertible Preferred Stock in a private, unregistered offering. The Series B-9 preferred shares, authorized up to 302,273 shares and convertible into a maximum of 565,007 shares of Class A common stock at an initial but periodically reset conversion price, carry no voting rights, rank pari passu with common stock for dividends and liquidation alongside other designated preferred series, and are subject to ownership and exchange caps, as well as optional and mandatory conversion features tied to regulatory filings and resale eligibility. In a related January 8, 2026 announcement, the company detailed that roughly $3 million in stated value of its resettable convertible preferred stock was provided as primary capital to Cork & Vines Fund I, LP, a fund focused on premium experiential and luxury dining investments, marking a second GP Primary Capital transaction with this manager and increasing the collateral backing Beneficient’s ExAlt loan portfolio by about $3 million of alternative asset interests, thereby expanding its GP Primary Commitment Program and reinforcing its positioning as a provider of fundraising-linked primary capital solutions to general partners.

The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.

Beneficient Regains Full Compliance With Nasdaq Listing Standards

On January 2, 2026, Beneficient received notification from a Nasdaq Hearings Panel that it had regained compliance with Nasdaq’s minimum bid price rule and the continued listing requirements for warrants, and the company disclosed on January 5, 2026, that it is now in full compliance with all Nasdaq Capital Market listing standards. The restored compliance removes an overhang related to its Nasdaq listing status and helps stabilize Beneficient’s market position as it continues to pursue its business model in alternative asset liquidity and services for underserved investors.

The most recent analyst rating on (BENF) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Beneficient stock, see the BENF Stock Forecast page.

Beneficient Appoints Peter T. Cangany Jr. as Chairman

Beneficient announced that its Board of Directors appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany brings decades of leadership in financial services, corporate governance, and financial reporting, having previously served as a director of Beneficient since 2019 and held senior leadership positions at Ernst & Young LLP for nearly 40 years. His appointment is expected to bolster Beneficient’s strategic approach and long-term shareholder value creation.

Beneficient Announces Reverse Stock Split Approval

On December 1, 2025, Beneficient‘s stockholders approved a reverse stock split of its Class A and Class B common stock at a ratio of 1-for-8, which was subsequently approved by the Board of Directors to take effect on December 15, 2025. This move is intended to help Beneficient regain compliance with Nasdaq’s minimum bid price requirement. The reverse stock split will reduce the number of shares issued and outstanding and proportionally decrease the number of authorized shares, while increasing the exercise or conversion price per share. Beneficient’s Class A Common Stock will continue trading under the symbol ‘BENF’ on a split-adjusted basis starting December 15, 2025.

Beneficient Mourns Passing of Chairman Thomas O. Hicks

On December 10, 2025, Beneficient announced the passing of Thomas O. Hicks, Chairman of its Board of Directors, who died on December 6, 2025, at the age of 79. Hicks was a pioneering figure in private equity and had a significant impact on the company and the city of Dallas. Beneficient’s Board and management are committed to honoring his legacy by continuing to execute the company’s mission with the vision and courage he exemplified.

Beneficient Approves Reverse Stock Split Proposal

On December 1, 2025, Beneficient held a Special Meeting of Stockholders where approximately 92.8% of the company’s total voting power was represented. During this meeting, stockholders approved two key proposals: a reverse stock split of the company’s common stock at a ratio between 1-for-5 and 1-for-100, and an adjournment of the meeting if necessary to secure further proxy votes. These approvals are significant for Beneficient’s operational strategies and shareholder engagement.